SKUT-1A

SKUT-1A appears in ChEMBL-derived assay indexing as a human uterine carcinoma cell line, and a PubMed-indexed medicinal-chemistry study used SKUT-1A proliferation assays to evaluate cyclin-dependent kinase inhibitors^[1][2]; The available sources support a uterine tumor-cell context and drug-response application, but they do not establish donor history, histologic subtype, repository accession, morphology, or equivalence to the separately recognized SK-UT-1 line. Accordingly, SKUT-1A should remain a distinct, partially characterized identifier rather than being silently standardized to SK-UT-1. Database records should request the original provider and authentication information before adding molecular phenotype, disease-of-origin detail beyond uterine carcinoma, or broader research uses.